Basic Information
Creon
0032-1203
Regulatory Information
0032-1203
BLA020725
C73585
March 6, 2024
USA
These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009
HUMAN PRESCRIPTION DRUG LABEL
107
Company Information
078458370
Active Ingredients
CETYL ALCOHOL
Code: 936JST6JCN
Class Code: IACT
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
Code: G4U024CQK6
Class Code: IACT
DIMETHICONE
Code: 92RU3N3Y1O
Class Code: IACT
POLYETHYLENE GLYCOL, UNSPECIFIED
Code: 3WJQ0SDW1A
Class Code: IACT
TRIETHYL CITRATE
Code: 8Z96QXD6UM
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
HYPROMELLOSE, UNSPECIFIED
Code: 3NXW29V3WO
Class Code: IACT
CARRAGEENAN
Code: 5C69YCD2YJ
Class Code: IACT
POTASSIUM CHLORIDE
Code: 660YQ98I10
Class Code: IACT
Active Moieties
PANCRELIPASE AMYLASE
Code: YOJ58O116E
PANCRELIPASE LIPASE
Code: 8MYC33932O
PANCRELIPASE PROTEASE
Code: 3560D81V50